Welcome to our dedicated page for Femto Technologies news (Ticker: BCAN), a resource for investors and traders seeking the latest updates and insights on Femto Technologies stock.
The BCAN news page aggregates historical news and press releases related to BYND Cannasoft Enterprises Inc., the Israeli-based integrated software and cannabis company that traded on Nasdaq under the symbol BCAN. These items provide context on how the company described its activities in CRM software, medical cannabis, and sexual wellness technology, as well as its later evolution into Femto Technologies Inc. as noted in SEC filings.
Readers can find coverage of capital markets transactions, including underwritten public offerings and a registered direct offering in which Aegis Capital Corp. acted as bookrunner or placement agent for BYND Cannasoft. The news flow also highlights the company’s product development milestones, such as progress on the EZ-G device, planned production agreements for the EZ-G device and capsules, and laboratory testing phases for AI-based treatment devices.
Company press releases discuss its Benefit CRM software for small and medium-sized businesses, the development of a cannabis-focused CRM platform, and licensing to engage in medical cannabis trading in Israel through agreements with licensed growers. Additional articles describe BYND Cannasoft’s intellectual property strategy, including PCT filings, provisional patent applications, and WIPO publication of the EZ-G device patent application.
Investors and observers can use this news archive to review how BYND Cannasoft communicated its plans in CRM, medical cannabis, and AI-enabled sexual wellness devices during the period when BCAN was its Nasdaq symbol, and to understand the background that preceded the later name change to Femto Technologies Inc.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) announced that its subsidiary, Zigi Carmel Initiatives & Investments LTD., filed U.S. Provisional Patent Application 63461609 on April 25, 2023. This patent covers a male treatment device that utilizes sensors to stimulate the male sexual organs based on user preferences, leveraging AI and machine learning. The device can upload data to the cloud for tailored user experiences. This marks the company's third patent application targeting the expanding sexual wellness market, projected to reach $115.92 billion by 2030. CEO Yftah Ben Yaackov highlighted the potential for AI technology in enhancing personal experiences in sexual wellness. The company also plans to file an international application for this device under the Patent Cooperation Treaty (PCT).
BYND Cannasoft Enterprises announced a positive opinion from the PCT regarding its AI-based Female Treatment Device, aimed at enhancing user satisfaction through advanced sensors and machine learning algorithms. The device is designed to personalize experiences related to sexual pleasure and medical needs. BYND Cannasoft plans to expedite the monetization of its patents as the AI market is projected to grow at a CAGR of 39.4%, reaching USD 422.37 billion by 2028. The device's functionality includes monitoring user responses, collecting data to adjust stimulation levels, and storing user preferences. The company has filed a US Provisional Patent Application and a full-scale PCT application to protect its technology. CEO Yftah Ben Yaackov expressed commitment to market this innovative device, anticipating significant impact within the sextech industry.
BYND Cannasoft Enterprises announced its plans to formulate a proprietary CBD oil for distribution outside of Israel, leveraging its recent patent application and a license from Israel's Medical Cannabis Unit. The company will market CBD-infused products for its AI-based and EZ-G devices, using a razor/razor blade model with low-margin durable products and high-margin consumables, aiming for approximately $15 million in sales by capturing 3% of Israel's $500 million medical cannabis market. In 2022, Israel imported over 33,000 kg of medical cannabis, marking its position as the world's largest importer.
BYND Cannasoft announced its entry into the $30 billion Sextech Industry with the filing of a U.S. Provisional Patent Application for a new AI-based female treatment device. The patent, filed by its subsidiary Zigi Carmel Initiatives & Investments, focuses on the device's mechanical structure and operation. Utilizing AI and machine learning, the device aims to enhance user experience by adjusting to physiological data and user preferences. CEO Yftah Ben Yaackov emphasized the importance of personalized technology in consumer products. The device represents a potential significant market opportunity as the Sextech market is projected to grow to $52.7 billion by 2026.
BACAN has filed a full-scale PCT application for its innovative EZ-G device, which utilizes AI technology to enhance sexual experiences by analyzing user data.
The prototype features sensors to monitor sexual conditions, allowing it to customize user interactions for optimal pleasure. The global sextech market is projected to reach $62.32 billion by 2030, indicating strong growth potential for the EZ-G device. CEO Yftah Ben Yaackov emphasized that the device aims to alleviate sexual and mental health issues while offering a revenue model through disposable CBD oil lubricant capsules, likened to a razor-and-blade strategy.